|
US3686320A
(en)
|
1965-03-25 |
1972-08-22 |
Fisons Pharmaceuticals Ltd |
Bis-phenoxy compounds
|
|
GB1144905A
(en)
|
1965-03-25 |
1969-03-12 |
Fisons Pharmaceuticals Ltd |
Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
|
|
US3777033A
(en)
|
1965-03-25 |
1973-12-04 |
Fisons Pharmaceuticals Ltd |
Bis-chromonyl pharmaceutical composi-tion and methods
|
|
US3686412A
(en)
|
1965-03-25 |
1972-08-22 |
Colin Fitzmaurice |
Compositions containing bis-chromonyl compounds for inhibiting antigen-antibody reactions
|
|
US3598122A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
|
US3993073A
(en)
|
1969-04-01 |
1976-11-23 |
Alza Corporation |
Novel drug delivery device
|
|
US3598123A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
|
US3720690A
(en)
|
1970-04-10 |
1973-03-13 |
Fisons Pharmaceuticals Ltd |
Pharmaceutically active bis-carboxychromone compounds
|
|
US3683320A
(en)
|
1970-05-08 |
1972-08-08 |
Bunker Ramo |
Coaxial cable connectors
|
|
CA958714A
(en)
|
1970-09-03 |
1974-12-03 |
Peter B. Johnson |
Bis-chromone derivatives
|
|
US3710795A
(en)
|
1970-09-29 |
1973-01-16 |
Alza Corp |
Drug-delivery device with stretched, rate-controlling membrane
|
|
US4069307A
(en)
|
1970-10-01 |
1978-01-17 |
Alza Corporation |
Drug-delivery device comprising certain polymeric materials for controlled release of drug
|
|
US3731683A
(en)
|
1971-06-04 |
1973-05-08 |
Alza Corp |
Bandage for the controlled metering of topical drugs to the skin
|
|
US3742951A
(en)
|
1971-08-09 |
1973-07-03 |
Alza Corp |
Bandage for controlled release of vasodilators
|
|
US3996934A
(en)
|
1971-08-09 |
1976-12-14 |
Alza Corporation |
Medical bandage
|
|
BE795384A
(fr)
|
1972-02-14 |
1973-08-13 |
Ici Ltd |
Pansements
|
|
US4152448A
(en)
|
1972-02-15 |
1979-05-01 |
Fisons Limited |
Method and composition for the treatment of a condition of the gastro intestinal tract
|
|
US3921636A
(en)
|
1973-01-15 |
1975-11-25 |
Alza Corp |
Novel drug delivery device
|
|
HK38179A
(en)
|
1973-12-19 |
1979-06-22 |
Fisons Ltd |
Topical compositions
|
|
US3993072A
(en)
|
1974-08-28 |
1976-11-23 |
Alza Corporation |
Microporous drug delivery device
|
|
US4151273A
(en)
|
1974-10-31 |
1979-04-24 |
The Regents Of The University Of California |
Increasing the absorption rate of insoluble drugs
|
|
US3972995A
(en)
|
1975-04-14 |
1976-08-03 |
American Home Products Corporation |
Dosage form
|
|
US4067992A
(en)
|
1975-09-10 |
1978-01-10 |
Fisons Limited |
Method of treating a psychiatric condition
|
|
US4077407A
(en)
|
1975-11-24 |
1978-03-07 |
Alza Corporation |
Osmotic devices having composite walls
|
|
US4031894A
(en)
|
1975-12-08 |
1977-06-28 |
Alza Corporation |
Bandage for transdermally administering scopolamine to prevent nausea
|
|
US4060084A
(en)
|
1976-09-07 |
1977-11-29 |
Alza Corporation |
Method and therapeutic system for providing chemotherapy transdermally
|
|
US4201211A
(en)
|
1977-07-12 |
1980-05-06 |
Alza Corporation |
Therapeutic system for administering clonidine transdermally
|
|
US4189571A
(en)
|
1978-02-07 |
1980-02-19 |
Fisons Limited |
Esters of cromoglycates
|
|
JPS5562012A
(en)
|
1978-11-06 |
1980-05-10 |
Teijin Ltd |
Slow-releasing preparation
|
|
US4230105A
(en)
|
1978-11-13 |
1980-10-28 |
Merck & Co., Inc. |
Transdermal delivery of drugs
|
|
US4229447A
(en)
|
1979-06-04 |
1980-10-21 |
American Home Products Corporation |
Intraoral methods of using benzodiazepines
|
|
US4268519A
(en)
|
1979-06-05 |
1981-05-19 |
Fisons Limited |
Method of treating otitis media
|
|
CA1146866A
(en)
|
1979-07-05 |
1983-05-24 |
Yamanouchi Pharmaceutical Co. Ltd. |
Process for the production of sustained release pharmaceutical composition of solid medical material
|
|
US4291015A
(en)
|
1979-08-14 |
1981-09-22 |
Key Pharmaceuticals, Inc. |
Polymeric diffusion matrix containing a vasodilator
|
|
FR2505798B1
(fr)
|
1981-05-14 |
1986-07-25 |
Pari Symac |
Perfectionnement aux dispositifs comportant un ressort helicoidal utilise comme organe de transfert, d'extraction, de dosage ou de melange
|
|
EP0084898B1
(en)
|
1982-01-22 |
1986-09-03 |
FISONS plc |
Liposome and sodium cromoglycate compositions, and methods for their preparation
|
|
US5116817A
(en)
|
1982-12-10 |
1992-05-26 |
Syntex (U.S.A.) Inc. |
LHRH preparations for intranasal administration
|
|
US4476116A
(en)
|
1982-12-10 |
1984-10-09 |
Syntex (U.S.A.) Inc. |
Polypeptides/chelating agent nasal compositions having enhanced peptide absorption
|
|
US4683135A
(en)
|
1983-07-27 |
1987-07-28 |
Yeda Research And Development Co., Ltd. |
DSCG binding protein and process for preparing same
|
|
US4996296A
(en)
|
1983-07-27 |
1991-02-26 |
Yeda Research & Development Co., Ltd. |
Cromolyn binding protein in highly purifed form, and methods for the isolation thereof
|
|
GB8322178D0
(en)
|
1983-08-17 |
1983-09-21 |
Sterwin Ag |
Preparing aerosol compositions
|
|
US4634699A
(en)
|
1983-11-30 |
1987-01-06 |
Burroughs Wellcome Co. |
Branched chain phenothiazine
|
|
GB8332450D0
(en)
|
1983-12-06 |
1984-01-11 |
Fisons Plc |
Method of treatment
|
|
US4596795A
(en)
|
1984-04-25 |
1986-06-24 |
The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services |
Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives
|
|
GB2167300B
(en)
|
1984-11-23 |
1988-11-23 |
Fisons Plc |
Formulations
|
|
JPH0662601B2
(ja)
|
1985-08-16 |
1994-08-17 |
京都薬品工業株式会社 |
クロモグリク酸誘導体および抗アレルギ−剤
|
|
US4923892A
(en)
|
1985-08-17 |
1990-05-08 |
Burroughs Wellcome Co. |
Tricyclic aromatic compounds
|
|
GB8520662D0
(en)
|
1985-08-17 |
1985-09-25 |
Wellcome Found |
Tricyclic aromatic compounds
|
|
US4755386A
(en)
|
1986-01-22 |
1988-07-05 |
Schering Corporation |
Buccal formulation
|
|
US5231170A
(en)
|
1986-08-27 |
1993-07-27 |
Paul Averback |
Antibodies to dense microspheres
|
|
US5312325A
(en)
|
1987-05-28 |
1994-05-17 |
Drug Delivery Systems Inc |
Pulsating transdermal drug delivery system
|
|
DE3879811T2
(de)
|
1987-08-25 |
1993-10-07 |
Kuebler Gmbh Dr |
Pharmazeutische Zusammensetzung und ihre Verwendung.
|
|
US4906476A
(en)
|
1988-12-14 |
1990-03-06 |
Liposome Technology, Inc. |
Novel liposome composition for sustained release of steroidal drugs in lungs
|
|
EP0413583A3
(en)
|
1989-08-18 |
1991-07-17 |
Dey Laboratories; Inc. |
Clear, stable cromolyn formulation
|
|
US5739136A
(en)
|
1989-10-17 |
1998-04-14 |
Ellinwood, Jr.; Everett H. |
Intraoral dosing method of administering medicaments
|
|
US5280784A
(en)
|
1990-09-19 |
1994-01-25 |
Paul Ritzau Pari-Werk Gmbh |
Device in particular and inhalating device for treating the lung and the respiratory tracts
|
|
US5753208A
(en)
|
1990-11-09 |
1998-05-19 |
Egis Gyogyszergyar |
Antiasthmatic aerosol preparation of sodium cromoglycate
|
|
US5633009A
(en)
|
1990-11-28 |
1997-05-27 |
Sano Corporation |
Transdermal administration of azapirones
|
|
EP1875917A3
(en)
|
1990-12-05 |
2012-11-28 |
The General Hospital Corporation |
Use of NO for the treatment or prevention of reversible pulmonary vasoconstriction
|
|
DE59107894D1
(de)
|
1991-03-21 |
1996-07-11 |
Ritzau Pari Werk Gmbh Paul |
Vernebler insbesondere zur Anwendung in Geräten für die Inhalationstherapie
|
|
DK0580860T4
(da)
|
1991-04-16 |
2005-03-21 |
Nippon Shinyaku Co Ltd |
Fremgangsmåde til fremstilling af en fast dispersion
|
|
US6123924A
(en)
|
1991-09-25 |
2000-09-26 |
Fisons Plc |
Pressurized aerosol inhalation compositions
|
|
DK0540774T3
(da)
|
1991-11-07 |
1995-07-10 |
Ritzau Pari Werk Gmbh Paul |
Væskeforstøver
|
|
DK0540775T3
(da)
|
1991-11-07 |
1997-08-25 |
Ritzau Pari Werk Gmbh Paul |
Forstøver især til anvendelse i apparater til inhalationsterapi
|
|
US5618842A
(en)
|
1991-12-31 |
1997-04-08 |
Lifegroup S.P.A. |
N-acyl derivatives of aminoalcohols with polycarboxylic acids able to modulate mast cells in inflammatory processes having neuroimmunogenic origin
|
|
US5340591A
(en)
|
1992-01-24 |
1994-08-23 |
Fujisawa Pharmaceutical Co., Ltd. |
Method of producing a solid dispersion of the sparingly water-soluble drug, nilvadipine
|
|
US5281420A
(en)
|
1992-05-19 |
1994-01-25 |
The Procter & Gamble Company |
Solid dispersion compositions of tebufelone
|
|
GB9214390D0
(en)
|
1992-07-07 |
1992-08-19 |
Fisons Plc |
Formulations
|
|
AU4198793A
(en)
|
1992-07-24 |
1994-01-27 |
Takeda Chemical Industries Ltd. |
Microparticle preparation and production thereof
|
|
DE4225928A1
(de)
|
1992-08-05 |
1994-02-10 |
Ritzau Pari Werk Gmbh Paul |
Zerstäubervorrichtung mit Heizeinrichtung
|
|
US5700485A
(en)
|
1992-09-10 |
1997-12-23 |
Children's Medical Center Corporation |
Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid
|
|
DE4310575C1
(de)
|
1993-03-31 |
1994-09-15 |
Ritzau Pari Werk Gmbh Paul |
Vorrichtung zum Erzeugen von Aerosolpulsen
|
|
GB9317752D0
(en)
|
1993-08-26 |
1993-10-13 |
Fisons Plc |
New pharmaceutical use
|
|
ATE168289T1
(de)
|
1993-12-17 |
1998-08-15 |
Pari Gmbh |
Zerstäuberdüse
|
|
US5508451A
(en)
|
1994-07-07 |
1996-04-16 |
Hoechst Celanese Corporation |
Process for the preparation of dialkali metal cromoglycates
|
|
US5665378A
(en)
|
1994-09-30 |
1997-09-09 |
Davis; Roosevelt |
Transdermal therapeutic formulation
|
|
US6000394A
(en)
|
1994-10-26 |
1999-12-14 |
Paul Rizau Pari-Werk Gmbh |
Generation of an aerosol of an exact dose
|
|
US5552436A
(en)
|
1995-04-03 |
1996-09-03 |
Ascent Pharmaceuticals, Inc. |
Process for treating hemangioma
|
|
US5576346A
(en)
|
1995-04-03 |
1996-11-19 |
Ascent Pharmaceuticals, Inc. |
Process for treating uremic pruritus
|
|
GB9507768D0
(en)
|
1995-04-13 |
1995-05-31 |
Glaxo Group Ltd |
Method of apparatus
|
|
DE19520622C2
(de)
|
1995-06-06 |
2003-05-15 |
Pari Gmbh |
Vorrichtung zum Vernebeln von Fluiden
|
|
SE9502244D0
(sv)
|
1995-06-20 |
1995-06-20 |
Bioglan Ab |
A composition and a process for the preparation thereof
|
|
GB9513218D0
(en)
|
1995-06-29 |
1995-09-06 |
Fisons Plc |
Inhalation device and method
|
|
EP0933084A4
(en)
|
1995-12-27 |
2000-07-12 |
Showa Pharm Chem Ind |
AQUEOUS AGENTS CONTAINING CROMOGLYN
|
|
DE19602628C2
(de)
|
1996-01-25 |
2000-06-29 |
Pari Gmbh |
Vernebler
|
|
US6929801B2
(en)
|
1996-02-19 |
2005-08-16 |
Acrux Dds Pty Ltd |
Transdermal delivery of antiparkinson agents
|
|
US6923983B2
(en)
|
1996-02-19 |
2005-08-02 |
Acrux Dds Pty Ltd |
Transdermal delivery of hormones
|
|
US5824669A
(en)
|
1996-03-22 |
1998-10-20 |
Nitromed, Inc. |
Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
|
|
AU2458697A
(en)
|
1996-04-18 |
1997-11-07 |
Alcon Laboratories, Inc. |
Calcium channel blockers as human conjunctival mast cell degranulation inhibitors for treating ocular allergic conditions
|
|
DE69732306T2
(de)
|
1997-01-16 |
2006-01-12 |
Massachusetts Institute Of Technology, Cambridge |
Zubereitung von partikelhaltigen arzneimitteln zur inhalation
|
|
US6126919A
(en)
|
1997-02-07 |
2000-10-03 |
3M Innovative Properties Company |
Biocompatible compounds for pharmaceutical drug delivery systems
|
|
WO1998056381A1
(en)
|
1997-06-09 |
1998-12-17 |
Bridge Pharma, Inc. |
Compounds with combined antihistaminic and mast cell stabilizing activities, intended for ophthalmic use
|
|
US6391452B1
(en)
|
1997-07-18 |
2002-05-21 |
Bayer Corporation |
Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations
|
|
DE19734022C2
(de)
|
1997-08-06 |
2000-06-21 |
Pari Gmbh |
Inhalationstherapiegerät mit einem Ventil zur Begrenzung des Inspirationsflusses
|
|
US5952353A
(en)
|
1997-09-19 |
1999-09-14 |
Auburn University |
Treating/preventing heart failure via inhibition of mast cell degranulation
|
|
CZ300758B6
(cs)
|
1997-09-29 |
2009-08-05 |
Nektar Therapeutics |
Práškovitý prípravek obsahující perforované mikrostruktury
|
|
US6433040B1
(en)
|
1997-09-29 |
2002-08-13 |
Inhale Therapeutic Systems, Inc. |
Stabilized bioactive preparations and methods of use
|
|
US5869090A
(en)
|
1998-01-20 |
1999-02-09 |
Rosenbaum; Jerry |
Transdermal delivery of dehydroepiandrosterone
|
|
US6365180B1
(en)
|
1998-01-20 |
2002-04-02 |
Glenn A. Meyer |
Oral liquid compositions
|
|
US6323219B1
(en)
|
1998-04-02 |
2001-11-27 |
Ortho-Mcneil Pharmaceutical, Inc. |
Methods for treating immunomediated inflammatory disorders
|
|
GB9807232D0
(en)
|
1998-04-03 |
1998-06-03 |
Univ Cardiff |
Aerosol composition
|
|
GB9810949D0
(en)
|
1998-05-22 |
1998-07-22 |
Hewlett Healthcare Limited |
Formulation
|
|
DE19827228C2
(de)
|
1998-06-18 |
2000-07-13 |
Pari Gmbh |
Flüssigkeitszerstäubervorrichtung
|
|
US6946144B1
(en)
|
1998-07-08 |
2005-09-20 |
Oryxe |
Transdermal delivery system
|
|
ES2234266T3
(es)
|
1998-07-24 |
2005-06-16 |
Jago Research Ag |
Formulaciones medicas para aerosoles.
|
|
CA2338680C
(en)
|
1998-08-04 |
2008-10-14 |
Jago Research Ag |
Medicinal aerosol formulations
|
|
AU5471199A
(en)
|
1998-08-07 |
2000-02-28 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
|
GB9824604D0
(en)
|
1998-11-11 |
1999-01-06 |
Hewlett Healthcare Limited |
Treatment of allergic conditions
|
|
US6660715B2
(en)
|
1998-11-19 |
2003-12-09 |
Massachusetts Institute Of Technology |
Nonaqueous solutions and suspensions of macromolecules for pulmonary delivery
|
|
US7074388B2
(en)
|
1998-12-10 |
2006-07-11 |
Kos Life Science, Inc. |
Water stabilized medicinal aerosol formulation
|
|
HK1042825A1
(zh)
|
1998-12-22 |
2002-08-30 |
The University Of North Carolina At Chapel Hill |
治疗气道疾病的化合物和方法以及气道药物的给药方法
|
|
BR0008590A
(pt)
|
1999-01-08 |
2001-10-30 |
Emisphere Tech Inc |
Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
|
|
ES2307482T3
(es)
|
1999-02-10 |
2008-12-01 |
Pfizer Products Inc. |
Dispersiones farmaceuticas solidas.
|
|
EP1173245B1
(en)
|
1999-05-03 |
2004-09-01 |
Battelle Memorial Institute |
Compositions for aerosolization and inhalation
|
|
US20020061281A1
(en)
|
1999-07-06 |
2002-05-23 |
Osbakken Robert S. |
Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
|
|
WO2001013892A2
(en)
|
1999-08-25 |
2001-03-01 |
Advanced Inhalation Research, Inc. |
Large porous particles by spray-drying
|
|
US6749835B1
(en)
|
1999-08-25 |
2004-06-15 |
Advanced Inhalation Research, Inc. |
Formulation for spray-drying large porous particles
|
|
US6586008B1
(en)
|
1999-08-25 |
2003-07-01 |
Advanced Inhalation Research, Inc. |
Use of simple amino acids to form porous particles during spray drying
|
|
US7129274B1
(en)
|
1999-11-05 |
2006-10-31 |
Emisphere Technologies Inc. |
Phenoxy carboxylic acid compounds and compositions for delivering active agents
|
|
DE19962110C2
(de)
|
1999-12-22 |
2003-06-12 |
Pari Gmbh |
Inhalationsvernebler mit einstückigem Ventilelement
|
|
US6596261B1
(en)
|
2000-01-25 |
2003-07-22 |
Aeropharm Technology Incorporated |
Method of administering a medicinal aerosol formulation
|
|
US20020009491A1
(en)
|
2000-02-14 |
2002-01-24 |
Rothbard Jonathan B. |
Compositions and methods for enhancing drug delivery across biological membranes and tissues
|
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
|
US8257744B2
(en)
|
2000-07-07 |
2012-09-04 |
Laboratorios Farmacéuticos Rovi, S.A. |
Pharmaceutical forms for the release of active compounds
|
|
UA81743C2
(uk)
|
2000-08-07 |
2008-02-11 |
Центокор, Инк. |
МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ
|
|
TWI327597B
(en)
|
2001-08-01 |
2010-07-21 |
Centocor Inc |
Anti-tnf antibodies, compositions, methods and uses
|
|
RU2318829C2
(ru)
|
2001-11-14 |
2008-03-10 |
Сентокор, Инк. |
Антитела против il-6, композиции, способы и применение
|
|
CA2466863A1
(en)
*
|
2001-11-29 |
2003-06-05 |
Emisphere Technologies, Inc. |
Oral pharmaceutical compositions comprising cromolyn sodium and an acylated amino acid
|
|
TWI329105B
(en)
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
|
US6596284B1
(en)
|
2002-04-30 |
2003-07-22 |
Thomas E. Fleming |
Treating eczema with a combination of isotonic saline ocean® and nasal mast cell stabilizers
|
|
JP2008522583A
(ja)
|
2002-06-14 |
2008-07-03 |
セントカー・インコーポレーテツド |
修飾“ｓ”抗体
|
|
US20040120956A1
(en)
|
2002-06-27 |
2004-06-24 |
Song Xiao-Yu R. |
CNGH0004 polypeptides, antibodies, compositions, methods and uses
|
|
US20050008638A1
(en)
|
2002-06-27 |
2005-01-13 |
Jin Lu |
CNGH0005 polypeptides, antibodies, compositions, methods and uses
|
|
AU2003272450A1
(en)
|
2002-09-13 |
2004-04-30 |
C. Steven Smith |
Novel composition and method for treatment of upper respiratory conditions
|
|
US7550133B2
(en)
|
2002-11-26 |
2009-06-23 |
Alexza Pharmaceuticals, Inc. |
Respiratory drug condensation aerosols and methods of making and using them
|
|
SE0203687D0
(sv)
|
2002-12-13 |
2002-12-13 |
Ian Harwigsson Med Adagit Fa |
Pharmaceutical Porous Particles
|
|
CA2520853A1
(en)
|
2003-03-28 |
2005-03-31 |
Centocor, Inc. |
Anti-amyloid antibodies, compositions, methods and uses
|
|
US7582297B2
(en)
|
2003-04-11 |
2009-09-01 |
Medimmune, Llc |
Methods of treating respiratory conditions
|
|
CA2525184C
(en)
|
2003-05-09 |
2012-10-30 |
Centocor, Inc. |
Il-23p40 specific immunoglobulin derived proteins, compositions, methods and uses
|
|
CA2531482A1
(en)
|
2003-06-30 |
2005-01-20 |
Centocor, Inc. |
Engineered anti-target immunoglobulin derived proteins, compositions, methods and uses
|
|
US20050026880A1
(en)
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a cromone for treatment of asthma or chronic obstructive pulmonary disease
|
|
DE10347994A1
(de)
|
2003-10-15 |
2005-06-16 |
Pari GmbH Spezialisten für effektive Inhalation |
Wässrige Aerosol-Zubereitung
|
|
US20050209141A1
(en)
|
2003-10-17 |
2005-09-22 |
Silver Randi B |
Mast cell-derived renin
|
|
CA2544924A1
(en)
|
2003-11-05 |
2005-05-19 |
Centocor, Inc. |
Methods and compositions for treating mcp-1 related pathologies
|
|
US20060078558A1
(en)
|
2003-11-12 |
2006-04-13 |
Whitsett Jeffrey A |
Diagnosis, prognosis and treatment of pulmonary diseases
|
|
DE10355559A1
(de)
|
2003-11-21 |
2005-06-23 |
Orthogen Ag |
Transskin
|
|
US20050191246A1
(en)
|
2003-12-13 |
2005-09-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Powders comprising low molecular dextran and methods of producing those powders
|
|
US8088935B2
(en)
|
2003-12-23 |
2012-01-03 |
Ironwood Pharmaceuticals, Inc. |
Compounds and methods for the treatment of asthma
|
|
IL160936A0
(en)
|
2004-02-05 |
2004-08-31 |
Scott A Cordray |
Nasal spray and wash
|
|
CA2557724A1
(en)
|
2004-02-27 |
2005-10-06 |
Centocor, Inc. |
Methods and compositions for treating il-13 related pathologies
|
|
CA2566161C
(en)
|
2004-05-14 |
2013-10-01 |
Emisphere Technologies, Inc. |
Aryl ketone compounds and compositions for delivering active agents
|
|
JP4468361B2
(ja)
|
2004-05-26 |
2010-05-26 |
株式会社リバース・プロテオミクス研究所 |
新規創薬ターゲットならびにこれに作用する医薬
|
|
WO2006029182A2
(en)
|
2004-09-07 |
2006-03-16 |
The La Jolla Institute For Molecular Medicine |
Use of mdl-100,907 for treatment of allergic and eosinophil mediated diseases
|
|
WO2006039470A2
(en)
|
2004-09-29 |
2006-04-13 |
Centocor, Inc. |
Anti- amyloid antibodies, compositions, methods and uses
|
|
CN101175479A
(zh)
|
2005-03-16 |
2008-05-07 |
霍尼韦尔国际公司 |
药物递送制剂、装置和方法
|
|
WO2006105538A2
(en)
|
2005-03-31 |
2006-10-05 |
Centocor, Inc. |
Methods and compositions for treating il-21 related pathologies
|
|
EP1712220A1
(en)
|
2005-04-15 |
2006-10-18 |
PARI GmbH Spezialisten für effektive Inhalation |
Pharmaceutical aerosol composition
|
|
AU2012238334A1
(en)
|
2005-06-30 |
2012-11-01 |
Abbvie Inc. |
IL-12/p40 binding proteins
|
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
GB0520794D0
(en)
|
2005-10-12 |
2005-11-23 |
Innovata Biomed Ltd |
Inhaler
|
|
US7566743B2
(en)
|
2005-11-18 |
2009-07-28 |
Mark Glazman |
System and method for medical treatment
|
|
EP1962869B1
(en)
|
2005-12-21 |
2013-03-20 |
SolAeroMed Inc. |
Treatment of respiratory diseases
|
|
EA019476B9
(ru)
|
2005-12-29 |
2020-07-14 |
Янссен Байотек, Инк. |
АНТИТЕЛА ПРОТИВ IL-23p19 И ИХ ПРИМЕНЕНИЕ
|
|
DE102006001113B3
(de)
|
2006-01-09 |
2007-06-28 |
Pari GmbH Spezialisten für effektive Inhalation |
Aerosoltherapievorrichtung
|
|
US8263645B2
(en)
|
2006-02-03 |
2012-09-11 |
Pari Pharma Gmbh |
Disodium cromoglycate compositions and methods for administering same
|
|
EP1991201B1
(en)
|
2006-02-10 |
2018-03-28 |
PARI Pharma GmbH |
Nebulised antibiotics for inhalation therapy
|
|
EP2001881A2
(en)
|
2006-03-07 |
2008-12-17 |
Endacea, Inc. |
Compositions and methods for treating respiratory disorders
|
|
US20080035141A1
(en)
|
2006-06-16 |
2008-02-14 |
Warner W R |
Aerosolized therapy kit
|
|
WO2008002893A2
(en)
|
2006-06-29 |
2008-01-03 |
Centocor, Inc. |
Anti-amyloid antibodies, compositions, methods and uses
|
|
US8445437B2
(en)
|
2006-07-27 |
2013-05-21 |
The Brigham And Women's Hospital, Inc. |
Treatment and prevention of cardiovascular disease using mast cell stabilizers
|
|
EP3910065B8
(en)
|
2006-09-08 |
2025-09-17 |
AbbVie Manufacturing Management Unlimited Company |
Interleukin -13 binding proteins
|
|
US20080078382A1
(en)
|
2006-09-20 |
2008-04-03 |
Lemahieu Edward |
Methods and Systems of Delivering Medication Via Inhalation
|
|
GB0621707D0
(en)
|
2006-10-31 |
2006-12-13 |
Univ London Pharmacy |
Formulations for delivery via pressurised metered dose inhalers
|
|
US20100144646A1
(en)
|
2006-11-03 |
2010-06-10 |
Blake Paterson |
Method of diagnosing and treating asthma
|
|
US20080175887A1
(en)
|
2006-11-20 |
2008-07-24 |
Lixiao Wang |
Treatment of Asthma and Chronic Obstructive Pulmonary Disease With Anti-proliferate and Anti-inflammatory Drugs
|
|
US20080227704A1
(en)
|
2006-12-21 |
2008-09-18 |
Kamens Joanne S |
CXCL13 binding proteins
|
|
CN101616583A
(zh)
|
2007-02-08 |
2009-12-30 |
爱密斯菲尔科技公司 |
苯烷基羧酸输送剂
|
|
US20080214491A1
(en)
|
2007-03-02 |
2008-09-04 |
Logsdon Craig D |
Methods of Inhibiting the Interaction Between S100 and the Receptor for Advanced Glycation End-Products
|
|
US8252807B2
(en)
|
2007-03-02 |
2012-08-28 |
Board Of Regents, The University Of Texas System |
Methods of inhibiting the interaction between S100 and the receptor for advanced glycation end-products
|
|
WO2008116165A2
(en)
|
2007-03-21 |
2008-09-25 |
Next Safety, Inc. |
Methods and systems of delivering medication via inhalation
|
|
US7897776B2
(en)
|
2007-04-23 |
2011-03-01 |
Salutria Pharmaceuticals Llc |
Sulfonamide containing compounds for treatment of inflammatory disorders
|
|
EP2030644A1
(en)
|
2007-08-31 |
2009-03-04 |
PARI Pharma GmbH |
Aerosols for sinunasal drug delivery
|
|
WO2009045291A2
(en)
|
2007-09-28 |
2009-04-09 |
The Brigham And Women's Hospital, Inc. |
Mast cell stabilizers in the treatment of obesity
|
|
MX2010004179A
(es)
|
2007-10-15 |
2010-08-04 |
Janssen Pharmaceutica Nv |
Anticuerpos anti-amiloide, composiciones, metodos y usos.
|
|
DE102007052380A1
(de)
|
2007-10-31 |
2009-05-07 |
Bitop Ag |
Osmolythaltige Zubereitungen zur Anwendung bei trockenen Schleimhäuten
|
|
CA2704997C
(en)
|
2007-11-06 |
2016-05-24 |
3M Innovative Properties Company |
Medicinal inhalation devices and components thereof
|
|
WO2009082341A1
(en)
|
2007-12-20 |
2009-07-02 |
Astrazeneca Ab |
Device and method for deaggregating powder 854
|
|
WO2009103067A2
(en)
|
2008-02-14 |
2009-08-20 |
The Children's Hospital Of Philadelphia |
Compositions and methods to treat asthma
|
|
WO2009131695A1
(en)
|
2008-04-25 |
2009-10-29 |
Nektar Therapeutics |
Oligomer-bis-chromonyl compound conjugates
|
|
EP2282769A4
(en)
|
2008-04-29 |
2012-04-25 |
Abbott Lab |
DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND ITS USES
|
|
US20100260668A1
(en)
|
2008-04-29 |
2010-10-14 |
Abbott Laboratories |
Dual Variable Domain Immunoglobulins and Uses Thereof
|
|
NZ589434A
(en)
|
2008-06-03 |
2012-11-30 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
|
KR20110016959A
(ko)
|
2008-06-03 |
2011-02-18 |
아보트 러보러터리즈 |
이원 가변 도메인 면역글로불린 및 이의 용도
|
|
US10517839B2
(en)
|
2008-06-09 |
2019-12-31 |
Cornell University |
Mast cell inhibition in diseases of the retina and vitreous
|
|
NZ603698A
(en)
|
2008-07-08 |
2014-03-28 |
Abbvie Inc |
Prostaglandin e2 dual variable domain immunoglobulins and uses thereof
|
|
TW201014602A
(en)
|
2008-07-08 |
2010-04-16 |
Abbott Lab |
Prostaglandin E2 binding proteins and uses thereof
|
|
US20100087455A1
(en)
|
2008-10-06 |
2010-04-08 |
Auspex Pharmaceuticals, Inc. |
Substituted xanthine compounds
|
|
US20110195924A1
(en)
|
2008-10-08 |
2011-08-11 |
Logsdon Craig D |
Methods of Inhibiting the Interaction Between S100P and the Receptor for Advanced Glycation End-Products
|
|
WO2010057214A2
(en)
|
2008-11-17 |
2010-05-20 |
Wayne State University |
Nanoparticles and porous particles and methods of making the same
|
|
AU2009322236B2
(en)
|
2008-12-04 |
2013-11-07 |
Abbvie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
|
CN105061376A
(zh)
|
2009-01-29 |
2015-11-18 |
通用医疗公司 |
色甘酸衍生物以及成像和治疗的相关方法
|
|
AU2010208637A1
(en)
|
2009-01-29 |
2011-08-04 |
Abbvie Inc. |
IL-1 binding proteins
|
|
US9925282B2
(en)
|
2009-01-29 |
2018-03-27 |
The General Hospital Corporation |
Cromolyn derivatives and related methods of imaging and treatment
|
|
CN102781470B
(zh)
|
2009-03-05 |
2016-01-20 |
Abbvie公司 |
Il-17结合蛋白
|
|
US8470805B2
(en)
|
2009-04-30 |
2013-06-25 |
Kaohsiung Medical University |
Processes for preparing piperazinium salts of KMUP and use thereof
|
|
JP2012525155A
(ja)
|
2009-05-01 |
2012-10-22 |
アボット・ラボラトリーズ |
二重可変ドメイン免疫グロブリンおよびこの使用
|
|
PL2248517T3
(pl)
|
2009-05-08 |
2014-08-29 |
Pari Pharma Gmbh |
Stężone formulacje farmaceutyczne stabilizujące komórki tuczne
|
|
TW201109438A
(en)
|
2009-07-29 |
2011-03-16 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
|
CN102612524A
(zh)
|
2009-09-01 |
2012-07-25 |
雅培制药有限公司 |
双重可变结构域免疫球蛋白及其用途
|
|
KR20120104542A
(ko)
|
2009-10-15 |
2012-09-21 |
아보트 러보러터리즈 |
Ｉｌ?１ 결합 단백질
|
|
TW201119676A
(en)
|
2009-10-15 |
2011-06-16 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
|
UY32979A
(es)
|
2009-10-28 |
2011-02-28 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
|
TR201000733A2
(tr)
|
2010-02-02 |
2011-08-22 |
Bi̇lgi̇ç Mahmut |
Flutikazon, tiotropyum ve sodyum kromoglikat içeren farmasötik bileşimler.
|
|
US9226983B2
(en)
|
2010-04-07 |
2016-01-05 |
Abbvie Inc. |
TNF-α binding proteins
|
|
AU2015200579A1
(en)
|
2010-04-07 |
2015-02-26 |
Abbvie Inc. |
TNF-alpha binding proteins
|
|
US8841417B2
(en)
|
2010-05-14 |
2014-09-23 |
Abbvie Inc. |
IL-1 binding proteins
|
|
AU2016222339B2
(en)
|
2010-05-14 |
2017-11-23 |
Abbvie Inc. |
IL-1 binding proteins
|
|
US8586044B2
(en)
|
2010-05-28 |
2013-11-19 |
Northwestern University |
Treatment of chronic pelvic pain syndrome
|
|
US9592220B2
(en)
|
2010-06-17 |
2017-03-14 |
Aradigm Corporation |
Diagnosis and treatment methods for entry of gastrointestinal contents into respiratory tract
|
|
JP5850932B2
(ja)
|
2010-07-21 |
2016-02-03 |
アストラゼネカ・アクチエボラーグＡｓｔｒａｚｅｎｅｃａ Ａｋｔｉｅｂｏｌａｇ |
吸入器
|
|
CA2809433A1
(en)
|
2010-08-26 |
2012-03-01 |
Abbvie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
|
WO2012061374A2
(en)
|
2010-11-02 |
2012-05-10 |
Abbott Laboratories |
Dual variable domain immunoglobulins and uses thereof
|
|
JP6009455B2
(ja)
|
2010-12-21 |
2016-10-19 |
アッヴィ・インコーポレイテッド |
Ｉｌ−１アルファおよびベータ二重特異的二重可変ドメイン免疫グロブリンおよびその使用
|
|
WO2012088094A2
(en)
|
2010-12-21 |
2012-06-28 |
Abbott Laboratories |
Il-1 binding proteins
|
|
WO2012088302A2
(en)
|
2010-12-22 |
2012-06-28 |
Abbott Laboratories |
Half immunoglobulin binding proteins and uses thereof
|
|
WO2012092594A2
(en)
|
2010-12-30 |
2012-07-05 |
Harish Ziv M D |
Preparations for topical prevention and/or treatment of oral allergic symptoms due to oral contact with fruits and/or vegetables
|
|
JP5634313B2
(ja)
*
|
2011-03-29 |
2014-12-03 |
富士フイルム株式会社 |
レジストパターン形成方法およびそれを用いたパターン化基板の製造方法
|
|
GB201110058D0
(en)
|
2011-06-15 |
2011-07-27 |
3M Innovative Properties Co |
Medicinal inhalation devices, valves and components thereof
|
|
US20140242174A1
(en)
|
2011-09-06 |
2014-08-28 |
Verona Pharma Plc |
Treating cough and tussive attacks
|
|
EP2797954A2
(en)
|
2011-12-30 |
2014-11-05 |
AbbVie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
|
CA2862433A1
(en)
|
2011-12-30 |
2013-07-04 |
Abbvie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
|
CN104540504A
(zh)
|
2012-01-18 |
2015-04-22 |
苏州泰飞尔医药有限公司 |
治疗肺部疾病的高穿透力前药组合物和医药组合物
|
|
GB2498746A
(en)
|
2012-01-26 |
2013-07-31 |
Innovata Biomed Ltd |
Inhaler which locks when empty
|
|
JP6231022B2
(ja)
|
2012-02-28 |
2017-11-15 |
アイシューティカ ホールディングス インク．Ｉｃｅｕｔｉｃａ Ｈｏｌｄｉｎｇｓ Ｉｎｃ． |
吸入可能な医薬組成物
|
|
US20150018396A1
(en)
|
2012-03-08 |
2015-01-15 |
President And Fellows Of Harvard College |
Prevention and treatment of respiratory infection with peroxisome proliferator activator receptor delta agonist
|
|
SG11201406142XA
(en)
|
2012-03-27 |
2014-10-30 |
Univ Duke |
Compositions and methods for the prevention and treatment of mast cell-induced vascular leakage
|
|
US10105500B2
(en)
|
2012-05-09 |
2018-10-23 |
Virginia Commonwealth University |
Dry powder inhaler (DPI) designs for producing aerosols with high fine particle fractions
|
|
BR112014029442A2
(pt)
|
2012-05-25 |
2017-06-27 |
Xlear Inc |
composições antimucosas à base de xilitol e métodos e composições relacionados
|
|
US9427534B2
(en)
|
2012-07-05 |
2016-08-30 |
Clement Clarke International Ltd. |
Drug delivery inhaler devices
|
|
TW201402608A
(zh)
|
2012-07-12 |
2014-01-16 |
Abbvie Inc |
Ｉｌ－１結合蛋白質
|
|
WO2014031610A1
(en)
|
2012-08-21 |
2014-02-27 |
Sanofi |
Methods for treating or preventing asthma by administering an il-4r antagonist
|
|
JP6499077B2
(ja)
|
2012-10-25 |
2019-04-10 |
ザ ジェネラル ホスピタル コーポレイション |
アルツハイマー病と関連疾患の治療のための併用療法
|
|
AU2013345062B2
(en)
|
2012-11-16 |
2018-02-08 |
Merck Sharp & Dohme Corp. |
Process for making agglomerates using acoustic mixing technology
|
|
WO2014115098A1
(en)
|
2013-01-26 |
2014-07-31 |
Mahesh Kandula |
Compositions and methods for the treatment of neurological diseases and inflammation
|
|
PE20151670A1
(es)
|
2013-03-15 |
2015-12-12 |
Abbvie Inc |
Proteinas de union especificas duales dirigidas contra tnf-alfa
|
|
US9861608B2
(en)
|
2013-05-23 |
2018-01-09 |
Aztherapies, Inc |
Methods for delivering cromolyn
|
|
CR20160093A
(es)
|
2013-08-23 |
2016-08-26 |
Afferent Pharmaceuticals Inc |
Moduladores del receptor p2x3 y p2x2/3 de diaminopiridina para el tratamiento de la tos aguda, sub aguda o cronica
|
|
AU2014340182B2
(en)
|
2013-10-22 |
2019-05-23 |
The General Hospital Corporation |
Cromolyn derivatives and related methods of imaging and treatment
|
|
US9492408B2
(en)
|
2013-10-24 |
2016-11-15 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Protection from chemical-induced acute lung injury
|
|
GB2522727B
(en)
|
2013-11-26 |
2017-01-25 |
Purity Health Pharma Ltd |
Pulmonary delivery devices
|
|
EP2883564A1
(en)
|
2013-12-16 |
2015-06-17 |
PARI Pharma GmbH |
Aerosol delivery device and method of operating the aerosol delivery device
|
|
EP3102939A4
(en)
|
2014-02-05 |
2018-02-28 |
Dana-Farber Cancer Institute, Inc. |
AGENTS THAT MODULATE RGMb-NEOGENIN-BMP SIGNALING AND METHODS OF USE THEREOF
|
|
PT3104853T
(pt)
|
2014-02-10 |
2020-01-14 |
Respivant Sciences Gmbh |
Tratamento com estabilizadores de mastócitos para distúrbios sistémicos
|
|
US20160367520A1
(en)
|
2014-02-10 |
2016-12-22 |
Patara Pharma, LLC |
Mast cell stabilizers for lung disease treatment
|
|
US20150273119A1
(en)
|
2014-03-26 |
2015-10-01 |
Snu R&Db Foundation |
Formulation comprising anti-scarring agents and biocompatible polymers for medical device coating
|
|
US20150306107A1
(en)
|
2014-04-24 |
2015-10-29 |
Jansfat Biotechnology Co., Ltd. |
SAA Derivative Compound Restores eNOS And Inhibits Oxidative Stress-Induced A Diseases In Hypoxia
|
|
WO2015161510A1
(en)
|
2014-04-25 |
2015-10-29 |
Jansfat Biotechnology Co., Ltd. |
Saa derivative compound restores enos and inhibits oxidative stress-induced diseases in hypoxia
|
|
US20150337315A1
(en)
|
2014-05-20 |
2015-11-26 |
Michael M. Grunstein |
Compositions and methods targeting signaling by the g protein beta-gamma subunit for the treatment of asthma
|
|
DE102014009164A1
(de)
|
2014-06-03 |
2015-12-03 |
Herbalist & Doc Gesundheitsgesellschaft Mbh |
Silikonölhaltige nasal anzuwendende Formulierungen
|
|
WO2015185656A1
(en)
|
2014-06-05 |
2015-12-10 |
Medizinische Universität Wien |
Methods of diagnosing chronic obstructive pulmonary disease (copd) using novel molecular biomarkers
|
|
EP3152328A2
(en)
|
2014-06-05 |
2017-04-12 |
Transgenion-International Institute For Regenerative Translational Medicine Gmbh |
Methods of diagnosing chronic obstructive pulmonary disease (copd) using novel molecular biomarkers
|
|
EP3152329A2
(en)
|
2014-06-05 |
2017-04-12 |
Transregion-International Institute For Translational Medicine Gmbh |
Methods of diagnosing chronic obstructive pulmonary disease (copd) using novel molecular biomarkers
|
|
US20170218091A1
(en)
|
2014-07-03 |
2017-08-03 |
Abbvie Inc. |
Monovalent binding proteins
|
|
WO2016011254A1
(en)
|
2014-07-16 |
2016-01-21 |
Henry J. Legere Md, Pa |
Combinations of antihistamines and leukotriene antagonists and methods of use thereof
|
|
WO2016052953A1
(ko)
|
2014-09-30 |
2016-04-07 |
주식회사 엘지화학 |
(메트)아크릴레이트 화합물, 이로부터 유도된 반복단위를 포함하는 코폴리머 및 호모폴리머
|
|
US20170235918A1
(en)
|
2014-10-25 |
2017-08-17 |
Sumner Bluffs, Llc. |
Systems and methods for determining compliance and efficacy of a dosing regimen for a pharmaceutical agent
|
|
WO2017011729A1
(en)
*
|
2015-07-16 |
2017-01-19 |
Patara Pharma, LLC |
Combination therapies for the treatment of lung diseases
|
|
WO2017027402A1
(en)
|
2015-08-07 |
2017-02-16 |
Patara Pharma, LLC |
Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
|
|
US10238625B2
(en)
|
2015-08-07 |
2019-03-26 |
Respivant Sciences Gmbh |
Methods for the treatment of mast cell related disorders with mast cell stabilizers
|
|
CN108289845A
(zh)
|
2015-09-14 |
2018-07-17 |
维吉思康科技公司 |
皮下、舌下和口服治疗用空间稳定载体、用于治疗哺乳动物的组合物和方法
|